Literature DB >> 11096559

Nonulcer Dyspepsia.

.   

Abstract

Dyspepsia is a heterogeneous symptom complex with differing symptom presentations, underlying pathophysiology and available treatments. Patients older than 50 years and those who have "alarm" symptoms or signs (eg, weight loss, dysphagia, vomiting, anemia, or heme-positive stool) should undergo an initial endoscopic evaluation. Empiric treatment without diagnostic testing may be used in the initial approach to young patients without alarm symptoms. For patients presenting with uncomplicated dyspepsia, initial testing for H. pylori is appropriate. If present, H. pylori infection is generally treated and symptoms are followed. In patients who do not have H. pylori infection or do not respond to H. pylori treatment, initial treatment with an H(2) blocker or promotility agent is appropriate empiric therapy. In some patients, gastroesophageal reflux disease (GERD) presents atypically with primarily dyspeptic symptoms. In these patients, a trial of gastric acid suppressant may help implicate GERD. For patients with nonulcer dyspepsia (ie, dyspeptic symptoms with negative endoscopy), prokinetic therapy may be the most effective empiric treatment.

Entities:  

Year:  1998        PMID: 11096559     DOI: 10.1007/s11938-998-0003-0

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  8 in total

Review 1.  Nonulcer dyspepsia: a look into the future.

Authors:  M Camilleri
Journal:  Mayo Clin Proc       Date:  1996-06       Impact factor: 7.616

Review 2.  AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.

Authors:  N J Talley; M D Silverstein; L Agréus; O Nyrén; A Sonnenberg; G Holtmann
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

3.  Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.

Authors:  S J Veldhuyzen van Zanten; C Cleary; N J Talley; T C Peterson; O Nyrén; L A Bradley; M Verlinden; G N Tytgat
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

4.  Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials.

Authors:  G Dobrilla; M Comberlato; A Steele; P Vallaperta
Journal:  J Clin Gastroenterol       Date:  1989-04       Impact factor: 3.062

5.  Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study.

Authors:  F Halter; B Miazza; R Brignoli
Journal:  Scand J Gastroenterol       Date:  1994-07       Impact factor: 2.423

Review 6.  Functional dyspepsia. Insights on mechanisms and management strategies.

Authors:  J R Malagelada
Journal:  Gastroenterol Clin North Am       Date:  1996-03       Impact factor: 3.806

7.  Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

Authors:  V Stanghellini; C Tosetti; A Paternico; G Barbara; A M Morselli-Labate; N Monetti; M Marengo; R Corinaldesi
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

8.  Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.

Authors:  R Jian; F Ducrot; A Ruskone; S Chaussade; J C Rambaud; R Modigliani; J D Rain; J J Bernier
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.